Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation.
Varma, A
Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation. [electronic resource] - Bone marrow transplantation 07 2016 - 999-1001 p. digital
Publication Type: Journal Article
1476-5365
10.1038/bmt.2016.28 doi
Aged
Female
Hematopoietic Stem Cell Transplantation--adverse effects
Hepacivirus
Hepatitis C--blood
Humans
Lymphoma--blood
Male
Middle Aged
Multiple Myeloma--blood
Prevalence
Proportional Hazards Models
Retrospective Studies
Risk Factors
Stem Cell Transplantation
Survival Rate
Transplantation, Autologous
Treatment Outcome
Viral Load
Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation. [electronic resource] - Bone marrow transplantation 07 2016 - 999-1001 p. digital
Publication Type: Journal Article
1476-5365
10.1038/bmt.2016.28 doi
Aged
Female
Hematopoietic Stem Cell Transplantation--adverse effects
Hepacivirus
Hepatitis C--blood
Humans
Lymphoma--blood
Male
Middle Aged
Multiple Myeloma--blood
Prevalence
Proportional Hazards Models
Retrospective Studies
Risk Factors
Stem Cell Transplantation
Survival Rate
Transplantation, Autologous
Treatment Outcome
Viral Load